New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. Where Do They Fit in the Established GDMT? Why Should You Aim for Quadruple Therapy?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. Where Do They Fit in the Established GDMT? Why Should You Aim for Quadruple Therapy?

By American Heart & Vascular Institute FEATURING Michelle Kittleson

0 views

September 9, 2020

Comments 0

Discover the MOA of an Incretin Medication for T2D

Primer on Diabetes Management

Feat. S. Inzucchi

12:04

Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

11:37

ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich

28:13

National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason

11:25

ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster

61:49

Obafemi Awolowo University

Management of Heart Failure

Feat. O. A. Akinyele

18:43

ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo

26:01

Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo

17:44

Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan

26:32

Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen

12:18

CCM® Therapy

HRS 2024: Cardiac Contractility Modulation - Don’t Wait!

Feat. R. Kahwash

13:58

CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood

19:20

National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne

21:10

National Lipid Association

Plant-based Diets for Improving Lipids

Feat. K. Williams

22:14

Practical Ways to Achieve Targets in Diabetes Care

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Feat. S. Nissen

19:30

ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim

40:17

American College of Cardiology

Heart Failure with Preserved Ejection Fraction: Current Perspectives…

Feat. S. Shah

06:16

CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov

06:23

CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile

Login

Login

Join VuMedi

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. Where Do They Fit in the Established GDMT? Why Should You Aim for Quadruple Therapy?

Recommended